Much attention has been paid to the supply of illicit drugs in the Middle East and war-torn Syria, but little has been focused on the patterns and implications of drug consumption in the region. However, a recent MedGlobal report reveals insightful data about Syria's emerging addiction crisis. The report notes that drug consumption has increased 300% since the outbreak of Syria's civil war, with high addiction rates associated with illicit substances, including captagon, crystal meth, heroin, cannabis, and other volatile substances. In this episode of the Contours podcast, the New Lines Institute’s Caroline Rose and Senior Non-Resident Fellow Dr. Karam Shaar discuss the report’s findings with MedGlobal President Dr. Zaher Sahloul and talk about the future of drug demand in Syria and beyond.